DERMATA THERAPEUTICS, INC. Public Float
DERMATA THERAPEUTICS, INC. (DRMA) had Public Float of $3.10 million as of 2025-06-30, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-26
- 2025-06-30: Entity Public Float $3.10M.
- 2024-06-28: Entity Public Float $1.60M.
- 2023-06-30: Entity Public Float $4.80M.
- 2022-06-30: Entity Public Float $4.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $3.10M 10-K · filed 2026-03-26 |
| 2024-06-28 | $1.60M 10-K · filed 2025-03-17 |
| 2023-06-30 | $4.80M 10-K · filed 2024-03-21 |
| 2022-06-30 | $4.00M 10-K/A · filed 2023-03-28 |
| 2022-03-17 | $0.00 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |